
浏览全部资源
扫码关注微信
纸质出版:2016
移动端阅览
邓华江,张双,明扬,刘洛同,万伟峰,葛红飞,谭亮,陈礼刚,冯华.环孢菌素A通过PI3K-Akt通路保护小鼠脑缺血再灌注后血脑屏障损伤[J].陆军军医大学学报(原第三军医大学学报),2016,38(01):32-37.
Deng Huajiang,Zhang Shuang,Ming Yang,Liu Luotong,Wan Weifeng,Ge Hongfei,Tan Liang,Chen Ligang,Feng Hua.Cyclosporine A repairs blood-brain barrier damage in mice after cerebral ischemia-reperfusion injury via PI3K-Akt pathway[J].J Amry Med Univ (J Third Mil Med Univ),2016,38(01):32-37.
邓华江,张双,明扬,刘洛同,万伟峰,葛红飞,谭亮,陈礼刚,冯华.环孢菌素A通过PI3K-Akt通路保护小鼠脑缺血再灌注后血脑屏障损伤[J].陆军军医大学学报(原第三军医大学学报),2016,38(01):32-37. DOI:
Deng Huajiang,Zhang Shuang,Ming Yang,Liu Luotong,Wan Weifeng,Ge Hongfei,Tan Liang,Chen Ligang,Feng Hua.Cyclosporine A repairs blood-brain barrier damage in mice after cerebral ischemia-reperfusion injury via PI3K-Akt pathway[J].J Amry Med Univ (J Third Mil Med Univ),2016,38(01):32-37. DOI:
目的 探讨环孢菌素A(cyclosporine A
CsA)对小鼠脑缺血再灌注后血脑屏障的影响及其可能机制。 方法 通过线栓法对C57BL/6J及载脂蛋白E基因敲除(ApoE
-/-
)小鼠建立大脑中动脉栓塞(middle cerebral artery occlusion
MCAO)模型,用不同剂量(10、20 mg/kg)CsA进行干预,并将两种小鼠各自分为5组:假手术组(Sham)、手术组(I/R)、溶剂组(Vehicle)、小剂量组(10 mg/kg CsA)及大剂量组(20 mg/kg CsA)。观察小鼠脑缺血再灌注后神经功能评分、梗死灶体积、脑组织水含量及伊文思蓝漏出量的变化情况,并用Western blot检测各组p-Akt及Claudin-5蛋白表达量的变化。 结果 ①神经功能评分结果显示:MCAO后小鼠出现严重的神经功能障碍,经CsA干预后其损伤情况明显缓解,且大剂量组优于小剂量组(P0.05);②小鼠在脑缺血再灌注后表现出现严重的脑水肿、脑梗死及伊文思蓝渗漏,且各组ApoE
-/-
小鼠表现得比C57小鼠更为明显(P0.05),而CsA能缓解这些症状,且大剂量组效果明显优于小剂量组(P0.05);③Western blot检测结果显示:ApoE
-/-
小鼠脑组织中p-Akt蛋白表达量高于C57小鼠,而Claudin-5相对较低(P0.05)。经MCAO处理后各组小鼠均出现p-Akt蛋白表达明显增高从而引起Claudin-5减少(P0.05),CsA干预后,该效应出现逆转,且大剂量组的效果明显优于小剂量组(P0.05)。 结论 CsA可保护脑缺血再灌注后血脑屏障的损伤,从而起到改善预后的作用,其机制与PI3K/Akt信号通路有关,而ApoE
-/-
可通过该途径加重脑梗死。
Objective To determine the effect of cyclosporine A (CsA) on blood-brain barrier after cerebral ischemia-reperfusion (I/R) injury in mice and investigate its possible mechanism. Methods Middle cerebral artery occlus
ion (MCAO) model were established by Longa’s method in C57 BL/6J mice and apolipoprotein E knockout (ApoE
-/-
) mice. Then the C57BL/6J mice and ApoE
-/-
mice were assigned into 5 groups
that is
sham operation group (n=5)
I/R group (n=14)
vehicle group (n=14)
low- and high- dose CsA intervention groups (10 and 20 mg/kg
given intraperitoneally in 15 min
and 24 and 48 h after model establishment
n=14). After neurological function was evaluated
the mice were sacrificed in 1
3
5 and 7 d after surgery
and the brain tissues were harvested for infarct volume
brain water content
and the permeability of blood-brain barrier (Evans blue leakage). Western blotting was used to detect the expression levels of p-Akt and Claudin-5. Results (1) Neurological function evaluation showed that MCAO resulted in severe neurological dysfunction in the mice
but CsA intervention obviously attenuated the injury
with the high-dose group superior to the low-dose group (P0.05). (2) Cerebral I/R injury induced severe cerebral edema
cerebral infarction and reduced leakage of blood-brain barrier
and the ApoE
-/-
mice were injured more heavily than the C57 mice (P0.05). However
CsA alleviated the symptoms
and the effects were more significant in the high- than low-dose intervention group (P0.05). (3) Western blot results showed that the protein level of p-Akt was higher
while that of Claudin-5 was lower in the brain tissue of normal ApoE
-/-
mice than normal C57BL/6J mice (P0.05). After MCAO
the expression of p-Akt was significantly increased and then Claudin-5 was decreased (P0.05). CsA inhibited the process
and the high-dose group had greater effect than the low-dose group (P0.05). Conclusion CsA repairs the blood-brain barrier damage induced by I/R injury
and then improves the prognosis
which is related with PI3K/Akt signal pathway. Besides
ApoE
-/-
mice have more severe cerebral infarction through this signal pathway.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621